Market Overview

I think you’ll love what you hear,
what you’ll see and the opportunities
that will be set before you.
- Jon Najarian

Needham Shrugs At Cognizant's President Resignation, Internal Probe News

Needham Shrugs At Cognizant's President Resignation, Internal Probe News

Needham shrugged off two key events reported by Cognizant Technology Solutions Corp (NASDAQ: CTSH) that impacted shares Friday. The firm thinks that the appointment of President following the resignation and internal prob, would not alter the forward-looking view on the stock.

Therefore, analysts maintained their Buy rating and $68 target price.

While viewing Gordon Coburn resignation as President as a sudden development, the brokerage thinks Rajeev Mehta filling the void would enable Cognizant ensure smooth transition. Therefore, the firm doesn't see any significant disruption in the operation.

Related Link: Some May View Cognizant As 'Uninvestable' Amid Near-Term Overhang

Needham thinks Cognizant notified the regulators about its internal investigation and isn't sure about the implications from operational and legal perspective. However, investors need to monitor the situation and watch out for any details in the upcoming earnings conference call or otherwise.

In a note, analysts said, "Given the early stage and scarcity of detail on the payments investigation, it does not currently alter our forward-looking view of the stock, but we will continue to monitor the situation. We attribute the fall in the stock today more to the investigation than the resignation itself, though investors may be concerned that the two events are related."

At time of writing, the stock traded down by $8.01, or 14.56 percent, to $46.99.

Latest Ratings for CTSH

May 2019DowngradesBuyHold
May 2019MaintainsNeutralNeutral
May 2019DowngradesOutperformNeutral

View More Analyst Ratings for CTSH
View the Latest Analyst Ratings

Posted-In: NeedhamAnalyst Color News Reiteration Legal Management Analyst Ratings Best of Benzinga


Related Articles (CTSH)

View Comments and Join the Discussion!

Latest Ratings

View the Latest Analytics Ratings
Don't Miss Any Updates!
News Directly in Your Inbox
Subscribe to:
Benzinga Trading Daily
Get pre-market outlook, mid-day update and after-market roundup emails in your inbox.
Market in 5 Minutes
Everything you need to know about the market - quick & easy.
Daily Analyst Rating
A summary of each day’s top rating changes from sell-side analysts on the street.
Thank You

Thank you for subscribing! If you have any questions feel free to call us at 1-877-440-ZING or email us at

Here's Why Ophthotech Is Trading Down On Regeneron's News

Worst Performing Industries For September 30, 2016